Pfizer bought G...
login
Shares
Bonds
π₯Pre-IPO
Dividends
Portfolio
More
ETF
Sectors
News
Calendar
Try for free
Login
×
Email
Password
Forgot your password?
Login
Resend my activation email
Need an account? Sign up.
Home
News
Global Blood Therapeutics
Pfizer bought Global Blood Therapeutics
10/5/22 at 16:56
Share at
Vladimir Petenev
News editor
press@blackterminal.com
Pfizer completed its acquisition of Global Blood Therapeutics for $5.4, or $68.5 per share.
Global Blood Therapeutics
Review
Source:
investors.pfizer.com
Vladimir Petenev
News editor
Share at:
Share this news
×
To leave a comment, you must be logged in
Write your comment first
News feed
Rusolovo reported for 9 months of 2024 by RAS
10/31/24
ROLO
Globaltrak reported for 9 months of 2024 by RAS
10/31/24
GTRK
Rosseti North Caucasus reported for 9 months of 2024 by RAS
10/30/24
MRKK
Rosinter reported for 9 months of 2024 by RAS
10/30/24
ROST
God Nisanov has withdrawn from the shareholders of Samolet Group
10/30/24
SMLT
APRI reported for 9 months of 2024 by RAS
10/30/24
APRI
RusHydro reported for 9 months of 2024 by RAS
10/30/24
HYDR
Lukoil reports for 9 months of 2024 by RAS
10/30/24
LKOH
Nizhnekamskshina reported for 9 months of 2024 by RAS
10/30/24
NKSH
Acron reports for 9 months of 2024 by RAS
10/30/24
AKRN
«
Previous
53
54
55
56
57
58
59
60
61
62
»
Next
BlackTerminal.com 2016 - 2025.
English (US)
English (US)
Π ΡΡΡΠΊΠΈΠΉ (Π Π€)
investors.pfizer.com investors.pfizer.com investors.pfizer.com
English (US) 